• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Bariatric Surgery Cuts Hepatic Steatosis in Obesity and T2DM Drugs
    November 30, 2021
    Sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are highly effective for reducing hepatic steatosis in patients with severe obesity and type 2 diabetes, with almost complete clearance of liver fat one year after surgery...
  • Interventions More Likely After RYGB Versus Sleeve Gastrectomy drugs
    January 16, 2020
    Among adults undergoing bariatric surgery, interventions, operations, and hospitalizations are more likely after Roux en Y gastric bypass (RYGB) than after sleeve gastrectomy (SG), according to a study published online Jan. 15 in JAMA Surgery.
  • Gastric Sleeve Tied to Lower Risk for Subsequent Procedures drugs
    December 31, 2019
    Patients undergoing vertical sleeve gastrectomy (VSG) appear to be less likely than matched patients undergoing Roux-en-Y gastric bypass (RYGB) to experience subsequent abdominal operative interventions ...

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service